Cite
Cryptococcal Disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal Variety on Clinical Manifestations and Outcome.
MLA
Mitchell, David H., et al. “Cryptococcal Disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal Variety on Clinical Manifestations and Outcome.” Clinical Infectious Diseases, vol. 20, no. 3, Jan. 1995, pp. 611–16. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=83198169&authtype=sso&custid=ns315887.
APA
Mitchell, D. H., Sorrell, T. C., Allworth, A. M., Heath, C. H., McGregor, A. R., Papanaoum, K., Richards, M. J., & Gottlieb, T. (1995). Cryptococcal Disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal Variety on Clinical Manifestations and Outcome. Clinical Infectious Diseases, 20(3), 611–616.
Chicago
Mitchell, David H., Tania C. Sorrell, Anthony M. Allworth, Christopher H. Heath, Alastair R. McGregor, Kelly Papanaoum, Michael J. Richards, and Thomas Gottlieb. 1995. “Cryptococcal Disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal Variety on Clinical Manifestations and Outcome.” Clinical Infectious Diseases 20 (3): 611–16. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=83198169&authtype=sso&custid=ns315887.